wedelolactone

Wedelolactone (IKK Inhibitor II) is a natural product derived from Eclipta prostrata that inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα, and exhibits anticancer, anti-inflammatory, and antioxidant activities. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells by downregulating PKCε, without inhibiting Akt. Wedelolactone inhibits 5-Lox with an IC50 value of 2.5 μM. Wedelolactone can be used in research on inflammation, tumors, liver disease, and immune-related diseases.

Wedelolactone (Standard) is a reference standard for research and analysis in studies involving Wedelolactone. Wedelolactone (IKK Inhibitor II) inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.

Demethylwedelolactone Sulfate (Demethylwedelolactone 3-sulfate) is a coumestan compound isolated from Eclipta prostrata L.

Isodemethylwedelolactone (Isodemethylwedelolacton) is a natual product,has Clotting activity.

Demethylwedelolactone is a natural product isolated from Eclipta alba, has trypsin inhibitory effect an IC50 of 3.0 μM. it exerts anti-invasive growth effect on breast cancer cells.

Eclipta alba extract is a versatile plant extract derived from the whole plant of Eclipta prostrata. It is rich in various bioactive compounds, such as wedelolactone, eclalbasaponins, ursolic acid, oleanolic acid, luteolin, and apigenin. Eclipta alba extract is a potent hepatoprotective agent that aids in improving liver function and shielding the liver from damage.